DEA on ’08 PSE needs
This article was originally published in The Tan Sheet
Executive Summary
The Drug Enforcement Agency seeks comments on its proposed revised assessment of 2008 annual U.S. needs of ephedrine, pseudoephedrine and phenylpropanolamine in a June 23 Federal Register notice. It will accept comments through July 23. DEA did not change the original projection assessment, with the proposed medical, scientific, research and production needs of ephedrine (for sale) estimated at 11,500 kg, pseudoephedrine (for sale) at 511,100 kg and phenylpropanolamine (for sale) at 5,545 kg. The projections are based on 2007 year-end inventory and disposition data from quota recipients. An interim final rule to apply the Combat Meth Act requires firms that use the substances to apply by each April 1 for the next year's manufacturing quotas ("1The Tan Sheet" July 16, 2007, p. 8)...
You may also be interested in...
Combat Meth Pseudoephedrine Manufacturing Quota Rule Effective – DEA
Firms using ephedrine, pseudoephedrine, and phenylpropanolamine in drug products must apply by April 1 each year for the following year's manufacturing quotas, under a July 10 interim final rule to implement the Combat Meth Act
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.